The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma

BACKGROUND: Standard of practice involves using transarterial therapy for multifocal hepatocellular carcinoma (HCC) alone and sorafenib only for more advanced HCC, but the sorafenib and transarterial therapy combination may provide greater efficacy. AIM: To evaluate the safety and efficacy of concur...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Cabrera, R., Pannu, D. S., Caridi, J., Firpi, R. J., Soldevila-Pico, C., Morelli, G., Clark, V., Suman, A., George, T. J., Nelson, D. R.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3807574/
https://ncbi.nlm.nih.gov/pubmed/21605146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2011.04697.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares